Skip to content

Author

Michael Vaine

We have 1 of 4 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Jul 2026

Discovery and Characterization of a Potent and Selective Oral Inhibitor of STAT6 for the Treatment of Allergic Diseases 2257118

STAT6 is a transcription factor downstream of IL-4 and IL-13 signaling that acts as a key driver of type 2 inflammation, which is associated with atopic dermatitis and asthma. Inhibition of the IL-4/IL-13 pathway is clinically validated for treatment of allergic diseases. Our aim is to develop an oral small molec...

K. Garlick, J. Sweeney, M. Chau et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.